RPRXRoyalty Pharma plc - Ordinary Shares - Class A
$55.22
$0.05
(0.09%)
Closed $55.02
$0.20
(0.36%)
After Hours
Reported EarningsMay 6
Mkt Cap$31.66B
Vol4.59M
Fundamentals
Mkt Cap
$31.66B
Volume
-
52W High
$56.07
52W Low
$33.37
PE Ratio
28.82
Avg. Volume
4.28M
EPS (Annual)
$1.78
Rev/Employee
$23,781,930.00
Earnings
May 06
About
Royalty Pharma Plc engages in the provision of drug development services. It operates as a funder of innovation across the biopharmaceutical industry, collaborating with innovators from academic institutions, research hospitals and not-for-profits through small and mid-cap biotechnology companies to global pharmaceutical companies. Its portfolio includes royalties, including AbbVie and J&J’s Imbruvica, Astellas and Pfizer’s Xtandi, Biogen’s Tysabri, Gilead’s HIV franchise, Merck’s Januvia, Novartis’ Promacta, Vertex’s Kalydeco, Orkambi, Symdeko and Trikafta, and five development-stage product candidates. The company was founded by Pablo Gerardo Legorreta and Rory B. Riggs in 1996 and is headquartered in New York, NY.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
100
Frequently Asked Questions
What is Market Cap of Royalty Pharma plc - Ordinary Shares - Class A?
What is the 52-week high for Royalty Pharma plc - Ordinary Shares - Class A?
What is the 52-week low for Royalty Pharma plc - Ordinary Shares - Class A?
What is Royalty Pharma plc - Ordinary Shares - Class A stock price today?
What was Royalty Pharma plc - Ordinary Shares - Class A stock price yesterday?
What is the PE ratio of Royalty Pharma plc - Ordinary Shares - Class A?
What is the Price-to-Book ratio of Royalty Pharma plc - Ordinary Shares - Class A?
What is the 50-day moving average of Royalty Pharma plc - Ordinary Shares - Class A?
How many employees does Royalty Pharma plc - Ordinary Shares - Class A have?
